sodium oxybate Xyrem
Selected indexed studies
- Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. (Drug Alcohol Depend, 2009) [PMID:19493637]
- Prescribing sodium oxybate for narcolepsy. (BMJ, 2016) [PMID:27126864]
- The sodium in sodium oxybate: is there cause for concern? (Sleep Med, 2020) [PMID:33022487]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The sodium in sodium oxybate: is there cause for concern? (2020) pubmed
- Sodium oxybate for cataplexy. (2006) pubmed
- Sodium oxybate for narcolepsy. (2006) pubmed
- Sodium oxybate-a new horizon for symptomatic treatment of RBD? (2023) pubmed
- Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. (2009) pubmed
- Prescribing sodium oxybate for narcolepsy. (2016) pubmed
- Use of sodium oxybate (Xyrem in patients with dual diagnosis of narcolepsy and sleep apnea. (2010) pubmed
- Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. (2009) pubmed
- Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study. (2024) pubmed
- Sleep, Narcolepsy, and Sodium Oxybate. (2022) pubmed